Filing Details

Accession Number:
0001209191-21-061153
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-20 16:32:01
Reporting Period:
2021-10-18
Accepted Time:
2021-10-20 16:32:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1720725 Oyster Point Pharma Inc. OYST () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1228684 Phd J William Link C/O Oyster Point Pharma, Inc.
202 Carnegie Center, Suite 109
Princeton NJ 08540
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-18 303,614 $14.63 1,057,976 No 4 S Indirect See Footnote
Common Stock Disposition 2021-10-18 242,943 $15.09 815,033 No 4 S Indirect See Footnote
Common Stock Disposition 2021-10-18 1,912 $14.63 6,518 No 4 S Indirect See Footnote
Common Stock Disposition 2021-10-18 1,531 $15.09 4,987 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 10,066 Direct
Common Stock 20,604 Indirect By Limited Partnership
Common Stock 1,273 Indirect By Trust
Common Stock 27,942 Indirect By LLC
Footnotes
  1. The sale of these shares was effected pursuant to a Rule 10b5-1 trading plan adopted by each of Versant Venture Capital IV, L.P. ("Versant IV") and Versant Side Fund IV, L.P. ("Versant Side Fund IV").
  2. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $14.00 to $14.995, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote to this Form 4.
  3. Shares held by Versant IV. The Reporting Person may be deemed to beneficially own the shares held by Versant IV as a managing member of Versant Ventures IV, LLC ("Versant Ventures IV"), its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  4. The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $15.00 to $15.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote to this Form 4.
  5. Shares held by Versant Side Fund IV. The Reporting Person may be deemed to beneficially own the shares held by Versant Side Fund IV as a managing member of Versant Ventures IV, its sole general partner. The Reporting Person disclaims beneficial ownership of the securities held by Versant Side Fund IV except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person, as applicable, is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  6. Shares held by Link Family Enterprise, LP. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.
  7. Shares held by The Link Family Trust. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the Trustee of The Link Family Trust.
  8. Shares held by Flying L Partners VII, LLC. The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Flying L Partners VII, LLC.